Four UNC startup companies are getting an $80,000 boost thanks to a federal grant.
The money is coming from Carolina KickStart, which is a program within the North Carolina Translational and Clinical Sciences Institute (NC TraCS), a medical research center funded by the National Institutes of Health that distributes grants.
“We help research go faster, be less expensive and more efficient,” said Michelle Maclay, spokeswoman for NC TraCS.
medical startups get funding
Carolina KickStart awarded $80,000 this year to four biomedical startup companies. One of the companies was started by a group of UNC and N.C. State University graduate students.
- Augment Medical is developing a wireless platform to improve the care of disabled patients in the hospital setting.
- Meryx Pharmaceuticals is a company developing a treatment for acute lymphoblastic leukemia.
- Glycan Therapeutics is creating therapies for thrombosis and tools to aid research in the study of sugar chains or glycobiology.
- Spirovation aims to create therapies for respiratory disease.
Carolina KickStart assists startup biomedical companies at UNC and works for the commercialization of new technologies. In addition to providing funding for new companies, it also hosts educational programs and networking events.
The program awarded money to four of the 12 companies that applied: Augment Medical, Meryx Pharmaceuticals, Glycan Therapeutics and Spirovation.